drugset / Trial / NCT00654654

Safety and Efficacy Study of Isolagen TherapyTM in Treatment of Facial Wrinkles and Creases

NCT00654654 ↗

Phase 2 Completed 50 enrolled Castle Creek Biosciences, LLC.
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate the safety profile and the treatment effect of autologous human fibroblasts and placebo when administered to facial wrinkles and creases

Timeline

Start
2007-03
Primary completion
2008-06
Completion
2008-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Autologous Human Fibroblasts (azficel-T) Unknown — Other

Indications

No indication recorded.